Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Erlong Zuoci Pills (Erlong Zuoci Wan) is a traditional Chinese medicine (TCM) formulation manufactured by Lanzhou Foci. It is presented as brownish-black honeyed pills for oral administration. The formula is designed to replenish the kidney and subdue hyperactivity of the liver, specifically targeting patterns of liver and kidney yin deficiency. Clinical indications include tinnitus, impairment of hearing (deafness), dizziness, and blurred vision. The formulation consists of a complex mixture of herbal and mineral ingredients, including prepared Rehmannia glutinosa, Dioscorea opposita, Cornus officinalis, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Bupleurum chinense, and Magnetitum. As a multi-component TCM product, it does not target a single molecular entity but rather acts through the synergistic effects of its constituent parts according to TCM principles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Erlong Zuoci Pills.